ATE357433T1 - 4-pyrimidinyl-n-acyl-l-phenylanine - Google Patents

4-pyrimidinyl-n-acyl-l-phenylanine

Info

Publication number
ATE357433T1
ATE357433T1 AT00989906T AT00989906T ATE357433T1 AT E357433 T1 ATE357433 T1 AT E357433T1 AT 00989906 T AT00989906 T AT 00989906T AT 00989906 T AT00989906 T AT 00989906T AT E357433 T1 ATE357433 T1 AT E357433T1
Authority
AT
Austria
Prior art keywords
phenylanine
pyrimidinyl
acyl
Prior art date
Application number
AT00989906T
Other languages
English (en)
Inventor
Achyutharao Sidduri
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE357433T1 publication Critical patent/ATE357433T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00989906T 1999-12-06 2000-11-28 4-pyrimidinyl-n-acyl-l-phenylanine ATE357433T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16908999P 1999-12-06 1999-12-06

Publications (1)

Publication Number Publication Date
ATE357433T1 true ATE357433T1 (de) 2007-04-15

Family

ID=22614222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00989906T ATE357433T1 (de) 1999-12-06 2000-11-28 4-pyrimidinyl-n-acyl-l-phenylanine

Country Status (35)

Country Link
EP (1) EP1237878B1 (de)
JP (1) JP3824935B2 (de)
KR (1) KR100522344B1 (de)
CN (1) CN1218943C (de)
AR (1) AR034401A1 (de)
AT (1) ATE357433T1 (de)
AU (1) AU783348B2 (de)
BR (1) BR0016195A (de)
CA (1) CA2392570C (de)
CO (1) CO5080772A1 (de)
CY (1) CY1106626T1 (de)
CZ (1) CZ303435B6 (de)
DE (1) DE60034061T2 (de)
DK (1) DK1237878T3 (de)
EG (1) EG24361A (de)
ES (1) ES2282162T3 (de)
HK (1) HK1054384B (de)
HR (1) HRP20020468B1 (de)
HU (1) HU229105B1 (de)
IL (2) IL149617A0 (de)
JO (1) JO2283B1 (de)
MA (1) MA26850A1 (de)
MX (1) MXPA02005564A (de)
MY (1) MY126972A (de)
NO (1) NO322866B1 (de)
NZ (1) NZ518828A (de)
PE (1) PE20010961A1 (de)
PL (1) PL207160B1 (de)
PT (1) PT1237878E (de)
RS (1) RS50371B (de)
RU (1) RU2266901C2 (de)
SI (1) SI1237878T1 (de)
TW (1) TWI256387B (de)
WO (1) WO2001042225A2 (de)
ZA (1) ZA200203533B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960597B2 (en) 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
CN1325480C (zh) 2000-08-18 2007-07-11 味之素株式会社 苯基丙氨酸衍生物
AR033765A1 (es) * 2001-05-22 2004-01-07 Syngenta Participations Ag Procedimiento para la preparacion de derivados 3-alquil-3h-isobenzofuran-1-ona 7-sustituidos.
JP4452899B2 (ja) 2001-12-13 2010-04-21 味の素株式会社 新規フェニルアラニン誘導体
KR20110098980A (ko) 2003-12-22 2011-09-02 아지노모토 가부시키가이샤 신규한 페닐알라닌 유도체
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
BRPI0514415A (pt) * 2004-08-16 2008-06-10 Merck & Co Inc composto, composição farmacêutica, e, uso de um composto
JP4784224B2 (ja) 2004-09-24 2011-10-05 味の素株式会社 糖鎖転移方法および糖鎖転移酵素
EP2091916A2 (de) * 2005-11-23 2009-08-26 AstraZeneca AB L-phenylalaninderivate und deren verwendung als integrinantagonisten
AR059224A1 (es) * 2006-01-31 2008-03-19 Jerini Ag Compuestos para la inhibicion de integrinas y uso de estas
WO2007091046A1 (en) * 2006-02-09 2007-08-16 Astrazeneca Ab Chemical compounds
CA2655573C (en) * 2006-06-19 2014-04-29 Toray Industries, Inc. Therapeutic or prophylactic agent for multiple sclerosis
CN104628654A (zh) 2007-09-17 2015-05-20 艾伯维巴哈马有限公司 抗感染嘧啶及其用途
CN105693626A (zh) 2007-09-17 2016-06-22 艾伯维巴哈马有限公司 治疗丙型肝炎的尿嘧啶或胸腺嘧啶衍生物
CN102746239B (zh) 2007-09-17 2016-02-10 艾伯维巴哈马有限公司 治疗丙型肝炎的尿嘧啶或胸腺嘧啶衍生物
WO2010075276A1 (en) * 2008-12-22 2010-07-01 Icl-Ip America Inc. Water miscible solvent based process for purifying a bisphosphate
US9216952B2 (en) 2010-03-23 2015-12-22 Abbvie Inc. Process for preparing antiviral compound
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
EP3461556A1 (de) 2010-07-16 2019-04-03 AbbVie Ireland Unlimited Company Phosphinliganden für katalytische reaktionen
EP3056486B1 (de) 2010-07-16 2018-07-11 AbbVie Ireland Unlimited Company Verfahren zur herstellung von zwischenverbindungen antiviraler verbindungen
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
WO2013110680A1 (en) * 2012-01-27 2013-08-01 F. Hoffmann-La Roche Ag Integrin antagonist conjugates for targeted delivery to cells expressing vla-4
US9447035B2 (en) * 2012-01-27 2016-09-20 Hoffmann-La Roche Inc. Integrin antagonist conjugates for targeted delivery to cells expressing VLA-4
WO2015048819A1 (en) 2013-09-30 2015-04-02 The Regents Of The University Of California Anti-alphavbeta1 integrin compounds and methods
DK3064491T3 (da) * 2013-10-29 2020-03-16 Ea Pharma Co Ltd Sulfonamidderivat og medicinsk anvendelse deraf
CA2981371A1 (en) 2015-03-10 2016-09-15 The Regents Of The University Of California Anti-alphavbeta1 integrin inhibitors and methods of use
HUE070112T2 (hu) 2018-10-30 2025-05-28 Gilead Sciences Inc 3-(Kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-dion-származékok mint alpha4beta7 integrin gátlók gyulladásos betegségek kezelésére
EP3873900B1 (de) 2018-10-30 2025-01-08 Gilead Sciences, Inc. Imidazo[1,2-a]pyridin-derivate als alpha4beta7 integrin-inhibitoren zur behandlung von entzündlichen erkrankungen
CN112996786B (zh) 2018-10-30 2024-08-20 吉利德科学公司 用于抑制α4β7整合素的化合物
JP7189369B2 (ja) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド アルファ４β７インテグリンの阻害のための化合物
JP7491996B2 (ja) 2019-08-14 2024-05-28 ギリアード サイエンシーズ， インコーポレイテッド α４β７インテグリンの阻害のための化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH516578A (de) * 1967-11-02 1971-12-15 Bayer Ag Verfahren zur Herstellung von heterocyclische Acylaminogruppen enthaltenden Arylsulfonylharnstoffen mit blutdrucksenkender Wirkung
JP2002512625A (ja) * 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
CA2291762A1 (en) * 1997-05-29 1998-12-03 Merck & Co., Inc. Biarylalkanoic acids as cell adhesion inhibitors
CN100369888C (zh) * 1997-08-22 2008-02-20 霍夫曼-拉罗奇有限公司 芳酰基苯丙氨酸衍生物
KR100615760B1 (ko) * 1997-08-22 2006-08-25 에프. 호프만-라 로슈 아게 엔-알카노일페닐알라닌 유도체
HK1045495A1 (zh) * 1999-01-22 2002-11-29 依兰制药公司 抑制vla-4介导的白细胞粘着的多环化合物

Also Published As

Publication number Publication date
JP2003516396A (ja) 2003-05-13
BR0016195A (pt) 2002-08-13
CO5080772A1 (es) 2001-09-25
NO322866B1 (no) 2006-12-18
MA26850A1 (fr) 2004-12-20
RU2266901C2 (ru) 2005-12-27
HUP0204081A2 (en) 2003-05-28
PE20010961A1 (es) 2001-09-26
IL149617A (en) 2007-10-31
KR20020063906A (ko) 2002-08-05
DE60034061T2 (de) 2007-12-13
NO20022633L (no) 2002-06-04
AR034401A1 (es) 2004-02-25
PL207160B1 (pl) 2010-11-30
EP1237878B1 (de) 2007-03-21
KR100522344B1 (ko) 2005-10-20
YU40402A (sh) 2005-03-15
RU2002117422A (ru) 2004-03-10
ES2282162T3 (es) 2007-10-16
EP1237878A2 (de) 2002-09-11
MY126972A (en) 2006-11-30
CY1106626T1 (el) 2012-01-25
CN1407972A (zh) 2003-04-02
HU229105B1 (en) 2013-07-29
DK1237878T3 (da) 2007-07-30
CN1218943C (zh) 2005-09-14
CZ20022351A3 (cs) 2003-04-16
HRP20020468A2 (en) 2004-04-30
ZA200203533B (en) 2003-08-04
CA2392570A1 (en) 2001-06-14
SI1237878T1 (sl) 2007-08-31
TWI256387B (en) 2006-06-11
WO2001042225A2 (en) 2001-06-14
RS50371B (sr) 2009-11-10
EG24361A (en) 2009-03-04
CA2392570C (en) 2010-05-11
CZ303435B6 (cs) 2012-09-12
WO2001042225A8 (en) 2002-06-06
HRP20020468B1 (en) 2009-02-28
MXPA02005564A (es) 2002-09-02
DE60034061D1 (de) 2007-05-03
PT1237878E (pt) 2007-06-18
NO20022633D0 (no) 2002-06-04
HK1054384A1 (en) 2003-11-28
IL149617A0 (en) 2002-11-10
AU2669601A (en) 2001-06-18
NZ518828A (en) 2004-03-26
WO2001042225A3 (en) 2002-02-21
PL357601A1 (en) 2004-07-26
HK1054384B (zh) 2005-12-09
HUP0204081A3 (en) 2003-07-28
JP3824935B2 (ja) 2006-09-20
JO2283B1 (en) 2005-09-12
AU783348B2 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
DE60002992D1 (de) Dreiphasenabscheider
DE60001240D1 (de) Laserdepiliergerät
ATA51899A (de) Handstempel
DE60009430D1 (de) Türtülle
DE60002808D1 (de) Propellerrotornabe
DE60034061D1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DE60001283D1 (de) Celluloseetherfilme
DE60001894D1 (de) Busschienenverbindungsstruktur
DE50015451D1 (de) Spülwannensystem
DE59909346D1 (de) Zylinderkopfdichtung
DE59910286D1 (de) Kniehebel-spannvorrichtung
DE50007953D1 (de) Beleuchtungsanordung
DE50008613D1 (de) Sicherungsring
DE50016100D1 (de) Gabtriebs
DE50006899D1 (de) Antistatikum
DE50012482D1 (de) Tibiamarknagel
DE60001471D1 (de) 4-Hydroxyisothiazolverbindungen
DE50003660D1 (de) Diacylhydrazinderivate
DE59906520D1 (de) Exzenterzahnradgetriebe
DE50006013D1 (de) Anschlagpuffer
DE60000940D1 (de) Wälzlagerstahl
DE50003259D1 (de) Textilie
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
ATE440824T1 (de) Nitro-sulfobenzamide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237878

Country of ref document: EP